SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-19-000698
Filing Date
2019-02-27
Accepted
2019-02-27 17:18:21
Documents
36
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bkit_10q.htm 10-Q 145365
2 CERTIFICATION bkit_ex311.htm EX-31.1 8577
3 CERTIFICATION bkit_ex312.htm EX-31.2 8577
4 CERTIFICATION bkit_ex321.htm EX-32.1 3460
11 bkit_10qimg2.jpg GRAPHIC 14433
  Complete submission text file 0001477932-19-000698.txt   926562

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bkit-20181130.xml EX-101.INS 99626
6 XBRL TAXONOMY EXTENSION SCHEMA bkit-20181130.xsd EX-101.SCH 14573
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bkit-20181130_cal.xml EX-101.CAL 19837
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bkit-20181130_def.xml EX-101.DEF 19966
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bkit-20181130_lab.xml EX-101.LAB 81976
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bkit-20181130_pre.xml EX-101.PRE 67027
Mailing Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001
Business Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001 (646) 453-4912
Blake Insomnia Therapeutics, Inc. (Filer) CIK: 0001556416 (see all company filings)

IRS No.: 460780380 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-55022 | Film No.: 19638894
SIC: 7200 Services-Personal Services